SMAD2 and atherosclerosis: The potential mechanism of preventing restenosis was to inhibit atherosclerosis formation and to attenuate intimal hyperplasia by downregulating Smad2/3 phosphorylation and TGF-β1 expression, promoting eNOS activity (24).